Recall Register

Food, drugs, devices › Philips North America Llc

Device recall: Philips Azurion Interventional Fluoroscopic X-ray System with Azurion R2.2 with LUC configuration start-up issue; Azurio

FDA enforcement event 89174 · Class II · initiated 12 Nov 2021 · status Terminated · terminated 5 Feb 2024

DeviceVoluntary: Firm initiated1 product recordCambridge, MA

Philips North America Llc (Cambridge, MA) initiated this device recall on 12 Nov 2021; FDA lists 1 product record under event 89174, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 89% of the 900 device enforcement events initiated in 2021 carry the same class.

Status: Terminated, terminated 5 Feb 2024. Initiation: voluntary: firm initiated. Philips North America Llc has 129 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Philips North America Llc, Cambridge, MA.

Reason for recall

"(1)Start-up problem: Intermittently at start-up of the system, the communication of the control unit that manages the movement of the stand is not established; (2) Emergency stop recovery problem-warm restart is not executed correctly and movement functionality is not available"

Distribution

"Worldwide distribution - US Nationwide distribution in the state of WA and the countries of France, Germany, Japan, Poland, United Kingdom."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0471-2022Philips Azurion Interventional Fluoroscopic X-ray System with Azurion R2.2 with LUC configuration start-up issue; Azurion R2.2 emergency stop recovery issue Model Numbers: 722221, 722228, 722225, 722068, 722226, 722078, 72222410 units (1 US and 9 OUS)Class IITerminated19 Jan 2022

Context

89%of 2021 device events are Class II900 events that year
1product record in this eventfirm median: 1
129events on this register for the firm

Other enforcement events for Philips North America Llc

InitiatedProduct (first record)TypeClassRecords
7 Aug 2026Philips Brilliance. Models: Brilliance iCT, Brilliance iCT Upgrades, Brilliance iCT SP. Software 4.1.10.x Product Codes:DeviceClass II4
1 Jul 2026Cardiac Workstation 5000. Product Number: 860439.DeviceClass II2
5 Jun 2026Philips Telemetry Monitor 5500 1.4 GHz. Model Number: 867232. Includes the following system descriptions: TELE Monitor 5DeviceClass II1
26 May 2026Philips Avalon Fetal Monitor, FM20, Part number M2702A, Part M2703ADeviceClass II2
1 May 2026DigitalDiagnost C90 Flex/Value/Chest/ER. Model Number: 712035.DeviceClass II1
7 Jan 2026Brilliance iCT; Product Code (REF): 728306;DeviceClass II4
12 Dec 2025Philips Smart-hopping 2.0 AP 1.4 GHz. Patient Monitor.DeviceClass II1
31 Oct 2025IntelliVue MP2. Product Number: M8102A.DeviceClass II22
29 Oct 2025Incisive CT; Software Version Number: 4.5, 5.0, 5.1;DeviceClass II2
13 Aug 2025Philips CT systems labeled as the following: 1. Brilliance CT 40 Channel, Model Number: 728235. 2. Brilliance CT 64 ChanDeviceClass II10

All 129 events for Philips North America Llc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "(1)Start-up problem: Intermittently at start-up of the system, the communication of the control unit that manages the movement of the stand is not established; (2) Emergency stop recovery problem-warm restart is not executed correctly and movement functionality is not available"

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution - US Nationwide distribution in the state of WA and the countries of France, Germany, Japan, Poland, United Kingdom."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 5 Feb 2024. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.